Skip to main navigation Skip to search Skip to main content

MM-008: A Phase 1 Trial Evaluating Pharmacokinetics and Tolerability of Pomalidomide + Low-Dose Dexamethasone in Patients with Relapsed or Refractory and Refractory Multiple Myeloma and Renal Impairment

  • Jeffrey Matous
  • , David S Siegel
  • , Sagar Lonial
  • , R. Donald Harvey
  • , Claudia Kasserra
  • , Yan Li
  • , Min Chen
  • , Thomas Doerr
  • , Lars Sternas
  • , Mohamed H. Zaki
  • , Christian Jacques
  • , Jatin J. Shah
  • Colorado Blood Cancer Institute, Denver, CO
  • Hackensack University Medical Center
  • Emory University
  • Celgene
  • University of Texas MD Anderson Cancer Center

Research output: Contribution to journalArticlepeer-review

Original languageAmerican English
JournalBlood
Volume124
Issue number21
DOIs
StatePublished - Nov 15 2013
Externally publishedYes

Disciplines

  • Medicine and Health Sciences
  • Pediatrics
  • Internal Medicine

Cite this